BCHE and early-onset autosomal dominant Alzheimer disease: ,118 Clinical trials and meta-analyses suggest that cholinesterase inhibitors, particularly donepezil, may be beneficial in combating CVD due to their anti-inflammatory properties and their ability to increase ACh levels in the heart, as observed in Alzheimer’s disease and dementia patients with CVD.119